secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0001193125-25-085773
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics cuts 21 of 26 full-time staff, initiates strategic review
------------------------------------------------------------------------------

- Workforce reduced by 21 of 26 full-time employees, effective April 30, 2025.
- Estimated $1.5M in cash severance and benefit costs, mostly in Q2 2025.
- Key affected employees to transition to consulting agreements.
- Company initiated process to explore strategic alternatives to extend capital resources.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525085773/0001193125-25-085773-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525085773/d792758d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-085773

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer